Search

everythinglearnresearchcommunity

for

Search:↓

Hair gets thinner, grayer, and changes texture with age due to genetics, environment, and cellular changes, affecting the growth cycle.

Some skin problems can be signs of diabetes or other metabolic diseases and recognizing them can help diagnose and treat these diseases early.

Small molecule IM boosts hair growth by changing stem cell metabolism.

Hair shaft dysplasias are abnormal hair conditions that can be inherited or acquired and may signal other health issues, with limited treatment options available.

Patients with myotonic dystrophy often have skin problems that suggest early aging and vitamin D issues, and the severity of these problems is linked to their genetic condition and vitamin D levels.

Micro-current stimulation may promote hair growth more effectively than standard treatments.

Minoxidil boosts elastin production, potentially helping skin diseases.

Minoxidil foam helps hair growth by increasing good proteins and decreasing bad pathways in men with hair loss.

Some skin diseases and their treatments can negatively affect male fertility.

The document emphasizes the importance of correctly identifying and classifying genetic hair disorders to help diagnose related health conditions.

Short telomeres contribute to aging and cancer, and while telomerase can delay aging, it may also promote cancer.

HSP90 and lamin A/C are crucial for hair growth and could be targets for treating hair loss.

Researchers found 44 proteins that change during different hair growth stages and may be important for hair follicle function.

PDCD4 is important for controlling skin cell growth and healing.

The document concludes that changes in eyelashes and eyelid skin can indicate various local and systemic diseases.

Hair changes can indicate systemic diseases or medication effects.

Low ERCC3 gene activity is linked to non-pigmented hair growth.

Mitochondrial therapy and platelet-rich plasma therapy both stimulated hair regrowth in aging mice, with mitochondrial therapy showing similar effectiveness to plasma therapy.

Pediatricians should treat some hair loss types in children and refer others to a dermatologist.

Minoxidil, finasteride, and low-level laser light therapy are effective FDA-approved treatments for hair loss.

Gray hair is caused by reduced melanin production or transfer issues, linked to aging and possibly health conditions, with treatments focusing on color camouflage.

The document concludes that periocular hair disorders have various causes and treatments, and proper evaluation by specialists is important for management and prognosis.

The study concluded that a protein important for hair strength is regulated by certain molecular processes and is affected by growth phases.

Most hair loss in children is caused by a few common conditions and is easy to diagnose, but rare types require careful evaluation.

Runx genes are important for stem cell regulation and their roles in aging and disease need more research.

A woman's hair changed to a dry, tangled texture that's hard to comb after treatment with spironolactone, suggesting the medication might cause such hair changes.

Impaired autophagy may cause hair loss by triggering early catagen.

Conditioned media from mesenchymal stem cells show promise for tissue repair and disease treatment, but more research is needed on their safety and effectiveness.

The document reports findings on genetic research, including ethical concerns about genome editing, improved diagnosis of mitochondrial mutations, solving inherited eye diseases, confirming gene roles in epilepsy, linking a gene to aneurysms, and identifying genes associated with age-related macular degeneration.

Genetics, stress, and health issues can cause early hair greying, which affects self-esteem, and there's no cure, only hair dye.